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Abstract
Background: Early and accurate diagnosis of malaria followed by prompt treatment reduces the risk of severe disease 
in malaria endemic regions. Presumptive treatment of malaria is widely practised where microscopy or rapid diagnostic 
tests (RDTs) are not readily available. With the introduction of artemisinin-based combination therapy (ACT) for 
treatment of malaria in many low-resource settings, there is need to target treatment to patients with parasitologically 
confirmed malaria in order to improve quality of care, reduce over consumption of anti-malarials, reduce drug pressure 
and in turn delay development and spread of drug resistance. This study evaluated the effect of malaria RDTs on health 
workers' anti-malarial drug (AMD) prescriptions among outpatients at low level health care facilities (LLHCF) within 
different malaria epidemiological settings in Uganda.
Methods: All health workers (HWs) in 21 selected intervention (where RDTs were deployed) LLHF were invited for 
training on the use RDTs. All HWs were trained to use RDTs for parasitological diagnosis of all suspected malaria cases 
irrespective of age. Five LLHCFs with clinical diagnosis (CD only) were included for comparison. Subsequently AMD 
prescriptions were compared using both a 'pre - post' and 'intervention - control' analysis designs. In-depth interviews 
of the HWs were conducted to explore any factors that influence AMD prescription practices.
Results: A total of 166,131 out-patient attendances (OPD) were evaluated at 21 intervention LLHCFs. Overall use of 
RDTs resulted in a 38% point reduction in AMD prescriptions. There was a two-fold reduction (RR 0.62, 95% CI 0.55-0.70) 
in AMD prescription with the greatest reduction in the hypo-endemic setting (RR 0.46 95% CI 0.51-0.53) but no 
significant change in the urban setting (RR1.01, p-value = 0.820). Over 90% of all eligible OPD patients were offered a 
test. An average of 30% (range 25%-35%) of the RDT-negative fever patients received AMD prescriptions. When the test 
result was negative, children under five years of age were two to three times more likely (OR 2.6 p-value <0.001) to 
receive anti-malarial prescriptions relative to older age group. Of the 63 HWs interviewed 92% believed that a positive 
RDT result confirmed malaria, while only 49% believed that a negative RDT result excluded malaria infection.
Conclusion: Use of RDTs resulted in a 2-fold reduction in anti-malarial drug prescription at LLHCFs. The study 
demonstrated that RDT use is feasible at LLHCFs, and can lead to better targetting of malaria treatment. Nationwide 
deployment of RDTs in a systematic manner should be prioritised in order to improve fever case management. The 
process should include plans to educate HWs about the utility of RDTs in order to maximize acceptance and uptake of 
the diagnostic tools and thereby leading to the benefits of parasitological diagnosis of malaria.
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Background
Early and accurate diagnosis of malaria followed by
prompt treatment reduces the risk of severe disease in
malaria endemic regions. Presumptive treatment of fever
with anti-malarials is widely practised to reduce malaria-
attributable morbidity and mortality especially at lower
level health facilities where microscopy is not readily
available [1-3]. Similarly, the integrated management of
childhood illness (IMCI) strategy and the Uganda malaria
treatment guidelines [4] encourage presumptive anti-
malarial therapy for children below five years. However,
with the current malaria treatment policy of using
artemisinin-based combination therapy (ACT) as first-
line therapy for malaria in many African countries, there
is increasing need to confirm malaria before therapy in
order to limit overuse of ACT, reduce programme costs
of anti-malarials, reduce drug pressure and delay emer-
gence of resistance against ACT [5]. Clinical algorithms
have been shown to be poorly specific for malaria [3] and
have, therefore, not been helpful in improving clinical
diagnosis. There is need for a paradigm shift by clinicians
in order to overcome reliance on clinical diagnosis and
treatment of malaria and actively consider alternative
causes of febrile illnesses.
Currently, the main stay of malaria diagnosis is micros-
copy, but this is not always available or feasible at low
level health care facilities (LLHCF) in resource limited
settings due to cost, lack of skilled manpower, accessories
and reagents required. Rapid diagnostic tests for Plasmo-
dium falciparum (RDTs) are potential tools for parasite-
based diagnosis and treatment of malaria at LLHCFs
since the tests are accurate in detecting malaria infections
[6] and are easy to use. Evidence shows that providing
RDTs in the context of formal health care settings may
have limited impact on clinicians' prescribing behaviour
[7,8], yet the cost benefits of improved diagnosis can only
be realized when treatment is consistent with test results.
The only data available on the usefulness of RDTs in
Uganda has been generated using controlled research to
document validity of the tests [6,9-12] in limited epidemi-
ological settings and there is no consideration of their
impact on anti-malarial drug consumption [13]. In addi-
tion, RDTs are not currently widely available in LLHCFs
and there is limited data on the utilization of RDT results
to influence prescription of anti-malarials. As part of a
process to inform implementation of RDT use at LLH-
CFs, Malaria Consortium (MC), in collaboration with the
National Malaria Control Programme (NMCP), con-
ducted an operational study on the effectiveness of RDT
use in fever management. At the time of this work, the
NMCP was planning to deploy RDTs in LLHF as a large
implementation evaluation that would guide policy
changes to shift from presumptive treatment to parasite-
based diagnosis and treatment. It is within this context
that this work was carried out to evaluate the effect of
RDT test results on health workers' anti-malarial pre-
scription practices in the management of fever at LLH-
CFs in different malaria epidemiological settings in
Uganda.
Methods
Study design
This implementation research was conducted using a
quasi-experimental design to evaluate the effectiveness of
RDTs in a public health system setting in Uganda. To
determine the influence of the use of RDTs on prescrip-
tion practices, two complimentary analysis designs were
employed; the 'pre - post' and the 'intervention - control'
comparisons. The data included a four months pre-RDT
deployment period and six months post-intervention (i.e.
RDT deployment period) comparison of anti-malarial
prescription at out patients departments (OPD). Retro-
spective data on anti-malarial prescriptions were
extracted from health facility records for the pre-RDT
deployment period. During the prospective phase of the
study, RDTs were introduced to support clinical diagnosis
within the intervention group of health facilities (HF with
CD+RDT), while within the comparison arm, health
workers continued to treat malaria based on clinical diag-
nosis (HF with CD only). Within each district, the inter-
v e n t i o n  a n d  c o m p a r i s o n  L L H C F s  w e r e  s e l e c t e d  t o  b e
similar in terms of grade, type, number and cadre of
health care providers, and availability of anti-malarials.
This piece of implementation research also included a
qualitative assessment of health worker and health centre
attendees experiences and acceptance of RDTs, which
have largely not been presented here.
Study setting
Malaria is endemic in 95% of Uganda with stable trans-
mission throughout the year. There are two rainy seasons;
the first occurs in March to May and the second in Sep-
tember to November. The pre-RDT deployment period
was during the months of March to June 2007. For the
RDT deployment period, RDTs (P.f™ ICT, manufactured
by ICT Diagnostics, South Africa) were deployed in five
districts, between July and December 2007. The study
was conducted in four different malaria epidemiological
settings as represented by the five purposively selected
districts; Kapchorwa; a hypo-endemic region with a
malaria parasite prevalence of <20%, Mubende; a meso-
endemic region with a malaria parasite prevalence of 20-
70%, and Iganga; a hyper-endemic region with malaria
parasite prevalence of >70% [14]. Jinja and Mbale were
included to represent the fourth epidemiological setting
of a population located in a relatively urbanised and peri-
urbanised stratum given that the health seeking behav-
iour and general health service delivery knowledge andKyabayinze et al. Malaria Journal 2010, 9:200
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practices could potentially vary with populations in more
rural settings [16]. The target number of LLHF from
which the sample was selected is as follows: Kapchorwa
10, Jinja 10 Iganga 15, Mbale 12 and Mubende 11. For
each district, four HCIII and one HCII were purposively
selected on the following basis: 1) current lack of func-
tional parasite-based diagnostic services, 2) no previous
involvement in a similar research, 3) over 200 suspected
malaria cases managed at the facility per week and 4)
availability of a recording system that comprised outpa-
tient registers, health management information system
data (HMIS) and drug consumption data. For the urban
and peri-urban settings, not all the health facilities
selected were within townships. RDT s were deployed at
four out of the five facilities, selected randomly as the
intervention group (HF with CD+RDT). The fifth health
centre was routinely monitored as the comparison group
with clinical diagnosis only (HF with CD). Similar data
were compiled monthly to compare between these two
groups during the RDT deployment period.
Intervention procedures
Overall, 135 health workers, from the selected health
facilities were trained based on a WHO training curricu-
lum [17] to cover concepts of parasite-based manage-
ment of malaria, use of RDTs, record keeping and waste
disposal. The additional training in record keeping was
limited to recording of the RDT results and did not cover
the collection of routine data for the health management
and information system (HMIS) that is reported monthly
from the LLHCFs. The main messages within the training
were to test all presumed malaria cases with RDTs
regardless of age or malaria endemicity seating, and initi-
ate treatment in accordance to the test results and Minis-
try of Health treatment guidelines. The health workers
were encouraged to use the RDTs but were not restricted
to use this approach. Given that the national policy at the
time still promoted presumptive treatment for children
under five years and/or clinical diagnosis [4], health
workers were at liberty to decide which diagnostic
approach to use. In fact, the treatment guidelines for
health workers state that "Any patient with fever or his-
tory of fever within the last 24 hours without evidence of
other diseases should be treated for malarial even with a
negative blood smear for malaria parasites" which to
some extent allows health workers to ignore the results of
a malaria parasite-based test.
Deployment of RDTs to the health facilities began one
week after the end of training. In addition to the RDT test
kit, it was necessary to provide accessory supplies that
included indelible markers, gloves, cotton wool, timers
and bins for disposal of sharp objects. A box of RDT test
kits included 25-cassettes, with lancets, sterile swabs and
running buffer. A histidine rich protein-2 (HRP-2) based
RDT was selected for this evaluation since P. falciparum
is responsible for over 95% of malaria cases and it
accounts for all severe malaria cases in Uganda [18]. A
patient received a diagnostic test for malaria based on a
clinic suspicion of malaria. Support supervision was pro-
vided by the research team and district health staff
through visits every fortnight in the first eight weeks and
thereafter every three months. Technical support super-
vision is routinely carried out by the district health staff
every three months. Health workers did not receive any
personal benefits as a result of their involvement in this
work. It was envisaged that RDT deployment at the end
of this evaluation would continue at these facilities and
others as part of NMCP's phased implementation of par-
asite-based diagnosis and treatment in readiness for pol-
icy change.
Type of data collected
Information from medical records
Relevant patient data were extracted from out-patient
case record books with specific emphasis on clinicians'
recorded decisions to diagnose and treat or refer sus-
pected malaria patients, based on presumptive or RDT-
driven diagnosis. Sources of these data were OPD regis-
ters and pharmacy ledger books. A pre-designed form
was used to collect this information on a monthly basis
during the RDT deployment period. Data on the other
medications prescribed were not captured.
Health worker interviews
Health workers were interviewed 6-8 weeks after the ini-
tial deployment of RDTs on a normal working day. The
targeted population were health workers in the out-
patient clinics and the sample included all health workers
that were on duty on the day of the assessment. HWs
w e r e  i n t e r v i e w e d  o n l y  o n c e  d u r i n g  t h e  e n t i r e  s t u d y
period. In-depth interviews were guided by structured
pre-defined questionnaires to minimise interviewing
errors. The questionnaires included open-ended ques-
tions to capture information regarding health worker's
perceptions on RDTs and opinions on AMD prescription
practices. Interviews were carried out at a monthly fre-
quency at the same visit when other data were collected.
Quality control
The data extraction form used to collect patient data and
the structured questionnaire used for the health worker
interviews were pre-tested. Eight research assistants were
trained to use the data collection tools and were regularly
supervised by three supervisors (two of whom are study
co-investigators) throughout the data collection period.
All completed data collection tools were checked for
accuracy and completeness at the end of each monthly
health facility visit. RDTs were distributed to the individ-
ual intervention health facilities and reserves kept at theKyabayinze et al. Malaria Journal 2010, 9:200
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district store where they existed. Manufacturer's storage
temperature specifications (4-30°C) were monitored both
at storage and during transportation. The district health
office was facilitated to conduct monthly support super-
vision
Ethical considerations
The study was conducted according to the principles of
the declaration of Helsinki and the international guide-
lines of biomedical research involving human subjects.
The study was approved by the Uganda National Council
for Science and Technology (UNCST) and the health
workers gave a written informed consent to participate in
the interviews.
Data management
Health workers were trained to record the results of para-
site testing with RDTs and the treatment decisions taken
in response. The practice of recording this information
was checked and corrected if necessary during support
supervision visits. The key variables for which data was
collected included the total number of fever patients seen
at OPD per month, number of OPD cases treated as
malaria, and number of patients clinically diagnosed as
malaria but not treated with anti-malarials. After the
introduction of RDTs, additional variables included num-
ber of patients with fever investigated with RDTs, num-
ber with RDT positive results treated and number with
negative RDT results that were treated with anti-malari-
als. The data were double entered into the study database
using a data-entry template in EpiData ("The EpiData
Association" Odense, Denmark). The two data files were
compared to check for completeness and conflicting
entries. One copy was then cleaned and exported to SPSS
12 (SPSS USA 2005) for further checks on completeness
of the data and subsequent analysis.
Data analysis
The primary study outcomes were proportion of anti-
malarial drug prescriptions and proportion of anti-malar-
ial drugs dispensed among the OPD patients. The sec-
ondary outcomes were the proportions of patients
treated based on test results for two age categories. Key
emergent themes on health worker's' perceptives and
opinions about the accuracy of the RDTs are presented as
proportions in order to illuminate some of the findings.
The proportions of fever cases treated with AMD based
on either clinical or RDT-driven diagnosis and treatment
were documented at all study LLHCFs. Anti-malarial pre-
scriptions and anti-malarials dispensed at service delivery
points were summarized as proportions for each month
at all LLHCFs based on pharmacy ledger books. Percent-
age change in anti-malarial prescription was computed as
difference between proportions of AMD prescriptions
among OPD patients pre and post intervention all
divided by the pre-intervention proportion. The impact
of RDTs on AMD prescription was estimated by comput-
ing risk ratios for the two analysis designs (pre - post and
intervention - control), after adjusted for clustering in
health facilities using survey data analysis methods in
STATA 10. The risk ratios have been estimated using neg-
ative binomial regression due to the over dispersion in
the data. Proportions of patients with RDT negative
results that received AMD prescriptions were compared
among children under 5 years and adults. For this sub-
analysis, Odds ratios with 95% confidence intervals were
calculated and interpreted as significant if p-value was
less than 0.05. Health worker responses to the interview
questions were manually analysed and the key findings
grouped into emergent themes. Numbers of responses in
line with each theme were documented.
Results
Descriptive characteristics of health facilities
Embedded in the phased implementation of RDT use at
LLHCFs in Uganda, the evaluation was conducted in 26
health facilities between March and December 2007. At
21 health facilities, RDTs were introduced to support par-
asite-based diagnosis of malaria (HF with CD+RDT) and
at five comparison facilities fever management continued
to rely on presumptive treatment/clinical diagnosis (HF
with CD only). Overall, 135 health workers from the HF
with CD+RDT were trained. Out of 161,131 patient con-
sultations made at the OPD during the study period,
37,718 (22.7%) were managed at HF with CD only.
Impact of RDTs on anti-malarial drugs prescription
Comparative analysis based on the 'pre-and post' RDT
deployment aspect of the evaluation, showed a 38% point
reduction in anti-malarial prescriptions in all study
health facilities when RDTs were introduced to support
malaria clinical diagnosis. The highest drop was in the
hypo-endemic malaria transmission settings with a two-
fold reduction in the AMD prescriptions (see Table 1).
During the pre-intervention period, more than half [54%
95% CI (53.9-54.7)] of all out-patient consultations (for all
diseases) were presumptively treated as malaria based on
clinical diagnosis. When RDT s were introduced to sup-
port diagnosis (post-intervention period), the proportion
of AMD prescriptions significantly dropped to one third
[33%, 95% CI (32.5%-33.2%)]. The percentage reduction
in the anti-malarials dispensed varied in a linear trend for
the different malaria transmission levels. Use of RDTs
resulted in a 2-fold decrease (RR = 0.52 95% CI 0.51-0.54)
in anti-malarial drug prescription of (59% drop) in the
hypo-endemic district of Kapchorwa. There were mini-
mal changes observed in hyper-endemic districts of
Iganga. When comparison between HF with CD and HF
with CD+RDT was performed, there was an overall 1.5-2Kyabayinze et al. Malaria Journal 2010, 9:200
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fold reduction (RR 0.68 95% CI 0.67-0.69) in anti-malarial
drug prescription in the intervention group compared to
the control group. The decrease in the prescriptions were
more pronounced in the meso-endemic (RR = 0.47
95%CI 0.45-0.50) located facilities yet no significant dif-
ference was observed in Jinja (RR1.01, p-value = 0.820)
when analysed as 'intervention -control' (see Table 2 and
Figure 1).
Utilisation of test kits
The majority (90%, 35,154) of the patients with suspected
malaria were investigated with RDTs after kits were intro-
duced. One example where fewer patients were tested
(76%) was in Jinja district during the month of July. The
explanation for this was lack of gloves for health workers
to perform the test.
Adherence to test results
Of all the patients tested with RDTs, an average of 30% of
the patients found to have negative RDT results were pre-
scribed AMD. However, the proportion of RDT negative
patients that were prescribed AMD declined slightly over
time, decreasing from 35% to 29% over the period of 6
months. On the other hand, only 83 (1%) of positive
patients were not prescribed AMD (see Table 3).
Sub analysis of patients with complete age information
(66%) was performed using a case-control approach. Of
the 16,386 tested, 6,915 (34%) were below five years. Chil-
dren <5 years were 1.4 times more likely to be offered a
test than the older group [(OR 1.43 95% CI 1.34-1.53) p-
value <0.0001]. When the test result was negative, chil-
dren under five years of age were 2.6 times more likely
[(OR 2.55 95% CI 2.33-2.81) p-value <0.001] to receive
anti-malarial prescriptions relative to older age group.
Forty-nine (49%) of the children under five years with
negative RDT results received AMD prescriptions com-
pared to 28% in the older age group [p < 0.001 (see figure
2)]. Almost of all patients (99%) with positive RDT results
received AMD prescription irrespective of age.
Health worker's opinions about the utilization of rapid 
diagnostic tests
During the study, all the 63 health workers who treated
patients in the intervention group of LLHCFs partici-
pated in the evaluation. Of these, 53 (84%) had been
trained in malaria diagnosis and management as part of
the study. Twenty-nine (46%) of all health workers inter-
viewed were nursing assistants (three months pre-service
training in medical care), 22 (35%) nurses, 8 (13%) clinical
officers and 4 (6%) laboratory technologists.
The health workers' opinions and prescription practices
on RDT use were grouped into two themes; a) accuracy
of test results and b) health workers' prescription prac-
tices (see Table 4). Majority (92%) of the respondents
health care workers believed that positive RDT results
were always truly positive (sensitivity), but only half (51%)
believed that negative RDT results were always truly neg-
ative (specificity), reasoning that the RDTs can miss a
true case of malaria. Almost all (98%) health care workers
said they communicate RDT s results to patients. Up to
44% of the health workers mentioned that they do not
always have to treat RDT positive patients and the possi-
Table 1: Anti-malarial prescription in 21 health facilities comparing 'Pre' (March - June 2007) to 'Post' RDTs (July - 
December 2007) intervention at 5 districts of Uganda
Malaria endemicity Measurements 'Pre'- RDTs 'Post'- RDTs % drop * RR [95% CI]^ p- value
District
Hyper-endemic OPD attendance 10,167 11,273
Iganga Anti-malarials prescribed (%) 5,725 (56) 4,744 (42) 25% 0.74[0.61-0.91] <0.001
Urban OPD attendance 4,749 9,536
Jinja Anti-malarials prescribed (%) 2,686(57) 3,076 (32) 44% 0.56[0.39-0.81] 0.003
Peri Urban OPD attendance 21,707 27,553
Mbale Anti-malarials prescribed (%) 11,736 (54) 9,796 (36) 33% 0.65[0.53-0.80] <0.001
Meso-endemic OPD attendance 8,842 14,385
Mubende Anti-malarials prescribed (%) 5,471 (62) 5,232 (36) 42% 0.60[0.47-0.76] <0.001
Hypo-endemic OPD attendance 8,164 12,032
Kapchorwa Anti-malarials prescribed (%) 5,002 (61) 3,072 (26) 57% 0.46[0.38-0.57] <0.001
All settings OPD attendance 53,629 74,784
Anti-malarials prescribed (%) 
[95%CI]
29117(54)[53.9-54.7] 24591(33)[32.5-33.2] 39% 0.62[0.55-0.70] <0.001
*Percentage point reduction between baseline (pre) and post intervention = [(pre-RDTs proportion-post RDT proportion)/pre-RDTs proportion]Kyabayinze et al. Malaria Journal 2010, 9:200
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ble reason for not treating may be due to the current
guidelines that recommend referral of severe malaria
cases. Twenty-three (40%) mentioned that they would
consider treating based on clinical suspicion despite a
negative RDT test result. Over 98% of the health workers
said they were willing and committed to performing
RDTs on a daily basis in the management of out-patients
who present with fever.
Discussion
Use of RDTs to support diagnosis resulted in a 39%
reduction in AMD prescriptions that translates to
approximately a 2-fold reduction in AMD prescriptions
across all epidemiological settings during the seven
months of this work. This evidence correlates with results
from Zanzibar where improved parasitological diagnosis
of malaria resulted into fewer unnecessary treatments
compared to presumptive treatment [19]. Similarly,
mathematical models have projected significant saving of
anti-malarial drugs with parasitological treatment of
malaria in medium to low medium transmission settings
in Tanzania and Mozambique [20-22]. These findings
imply that use of RDTs in malaria case management lim-
its unnecessary use of anti-malarial drugs and could
potentially reduce the programme costs of malaria ther-
apy in resource-limited settings (RLS).
Over 90% of outpatients with suspected malaria
received rapid diagnostic testing for malaria during the
study period and this was similar across all different
malaria transmission settings. This result was contrary to
previous studies in Zambia where only 20% of out-
patients with suspected malaria had received rapid diag-
nostic testing one year after introduction of RDTs in the
health care facilities [8]. The high utilization of RDTs by
health workers in the diagnosis and treatment of malaria
could be due to the positive attitudes of the health work-
ers towards the accuracy of RDTs as reported in the in-
depth interviews. It was, therefore, interesting to demon-
strate that health workers at LLHCFs are capable of
switching from presumptive treatment to parasite based
diagnosis and treatment of malaria following a one-day
training coupled with provision of RDT kits in the health
facilities and support supervision. Findings from this
study, together with the evidence that RDTs have a very
high negative predictive value in similar field settings [6]
support the current WHO recommendations on parasite-
based diagnosis that RDTs can be used widely in fever
case management to exclude malaria infection in malaria
endemic settings [23]. However, it is still questionable
whether the observed and demonstrated momentum by
health workers to shift from presumptive to parasite-
based diagnosis of malaria, in this study, will be sus-
tained, with the anticipated scale up of malaria RDTs by
the NMCP.
It is highly probable that the decreasing trend of pre-
sumptive treatment in AMD prescriptions observed in
Table 2: Anti-malarial prescription in 26 health facilities comparing 'observational' (control) arm to the 'intervention' arm 
when RDTs where used to support malaria diagnosis between March-December 2007 at 5 districts of Uganda
Malaria endemicity Measurements Baseline Control 
arm n = 5
Post-era Control 
arm n = 5
Intervention arm 
n = 21
RR [95% CI]* p- value
District
Hyper-endemic OPD attendance 2,475 3,344 11,273
Iganga Anti-malarials prescribed (%) 1,186 (48) 1,941 (58) 4,744 (42 ) 0.72[0.70-0.76] <0.001
Urban OPD attendance 1,696 2,614 9,536
Jinja Anti-malarials prescribed (%) 540 (31) 809 (31) 3,076 (32) 1.01[0.99-1.05] 0.820
Peri Urban OPD attendance 4,153 5,298 27,553
Mbale Anti-malarials prescribed (%) 2,656 (64) 3,444 (65) 9,796 (36) 0.55[0.50-0.61] <0.001
Meso-endemic OPD attendance 2,040 4,160 14,385
Mubende Anti-malarials prescribed (%) 1,143(56) 2,927 (70) 5,232 (36) 0.47[0.45-0.50] <0.001
Hypo-endemic OPD attendance 3,555 7,594 74,784
Kapchorwa Anti-malarials prescribed (%) 2,094(59) 3,797 (50) 3,072 (25) 0.52[0.51-0.53] 0.005
All settings OPD attendance 13,919 23,010 74,784
Anti-malarials prescribed (%) 
[95%CI]
7,619 (56)[51.0-
58.6]
12,918 (55)[55.5-
56.8]
25929(35)[32.5-
37.2]
0.68[0.67-0.69] 0.005
*Risk Ratio = Rate [1]/Rate [2]. Rate 1 and rate 2 are the proportion of all OPD that are prescribed anti-malaria at the observation (control) and 
intervention health facilities respectively during the interval July-December 2010Kyabayinze et al. Malaria Journal 2010, 9:200
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this work, may have been as a result of our regular visits
to the health facilities to support and guide health work-
ers in fever case management with RDTs. If this is the
case, the need for continued technical supportive super-
vision following comprehensive training on parasite-
based malaria case management is important in order to
ensure sustained reduction in unnecessary anti-malarial
drug use. In addition, Uganda NMCP may consider col-
lecting evidence on the key determinants for sustained
use of malaria RDTs and the trends of AMD prescription
or consumption, following the implementation of the
RDT-led parasitological based diagnosis and treatment
policy. The Uganda NMCP should invest in monitoring
and evaluation of the impact of RDT use on AMD pre-
scriptions as well as patient treatment outcomes in
malaria endemic regions.
About a third of the patients that tested negative with
RDTs still received AMD prescriptions. These findings
are comparable to reports from Ghana and Kenya where
35-55% of patients with negative RDT results were pre-
scribed AMD [24,25]; rates that are lower than previous
reports from a randomised trial in Burkina Faso where up
to 80% of RDT-negative patients were prescribed AMD
[26]. These data reflect the reluctance of some health
workers to shift from presumptive therapy even when
RDT results are available and thus creates concerns about
the likely anti-malarial drug wastage in addition to expos-
ing patients to the dangers of inappropriate treatment.
Some health workers argued that negative microscopy
results do not exclude malaria infections because of the
possibility of sequestration of malaria parasites from
peripheral blood [27]. However it is important to note
that this scenario does not apply to RDTs since RDTs
detect presence of malaria antigen rather than the pres-
ence of parasites. During the interviews, the health work-
ers mentioned that they treat RDT-negative patients
because they are afraid of challenges of severe malaria
given the long distance to the referral hospitals and HC
IV in case the need arises. Similarly, among patients with
negative RDT results, children under five years were
nearly 3 times more likely to receive anti-malarials rela-
tive to the older patients; a practice that is in line with the
Figure 1 Anti-malarial prescriptions among outpatients at 26 lower-level health facilities (HCII and III) in Uganda between March and De-
cember, 2007. The trend of anti-malarial prescriptions comparing the health facilities where interventions with RDTs were deployed showing the 
"before" and "after" period. 21 Health facilities were provided RDTs in the month of June and these were compared to 5 health facilities where pre-
sumptive diagnosis was maintained until December.
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
March April May June July Aug Sept Oct Nov Dec 
Time in Months
Clinical Dx (n=5 HCs) 
RDTs used (n=21 HCs) 
Intervention with RDTs 
%
 
g
i
v
e
n
 
a
n
t
i
-
m
a
l
a
r
i
a
l
s
 Kyabayinze et al. Malaria Journal 2010, 9:200
http://www.malariajournal.com/content/9/1/200
Page 8 of 10
Table 3: Out patient suspected malaria patients investigation and treatment at the 21 intervention peripheral health 
facilities II & III after introduction of rapid diagnostic tests between Julys - December 2007 in five districts of Uganda
Parameter or measurement July Aug Sept Oct Nov Dec
OPD attendances 14,940 15,354 10,927 13,265 9,561 10,737
Presumed malaria 8,041 7,733 5,844 6,576 5,430 5,412
(%)* (40%) (41%) (40%) (37%) (42%) (40%)
Anti-malaria prescriptions 5,143 5,550 3,815 4121 3,486 3,814
RDT-negative treated 871 1,056 787 828 585 534
% RDT negatives 35.0 34.4 33.9 29.4 27.3 29.0
treated as malaria(CI) (20-50) (19-50) (23-45) (19-40) (15-39) (19-39)
Risk ratio^ 0.71[0.53-0.96] 0.60[0.58-0.63] 0.64[0.48-0.87] 0.59[0.42-083] 0.68[0.50-0.92] 0.67[0.46-0.97]
p-value 0.029 <0.001 0.008 0.004 0.023 0.05
*Proportion of all Out-Patients that presented with symptoms suggestive of malaria
^ Risk ratio comparing anti-malarials prescribed in the observation arm and intervention arms
Figure 2 Age groups of patients treated on basis of negative RDT results at 21 health care facilities in 5 districts of Uganda between July 
and December, 2007. All patients that were negative after testing with RDTs were stratified according to age. Proportions of patients with RDT neg-
ative results that received AMD prescriptions were compared among children under 5 years and adults. Half of the children under 5 years with nega-
tive RDT results received AMD compared to 28% in the older age group (p < 0.001).
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national malaria treatment policy (Sept 2005) that
encourages presumptive treatment of malaria to reduce
malaria-associated morbidity and mortality among chil-
dren under five years [18]. These arguments have also
been advanced by English and others in suggesting that
there is still a role for presumptive treatment even when
RDTs are now widely available [28]. However, a recent
study in Uganda showed that it was safe to withhold
treatment for febrile smear negative patients for all age
groups [29]. It is also encouraging to know that in Zanzi-
bar, the health workers adhered to the RDT results in pre-
scribing anti-malarial treatment[19], without any
negative health outcomes although the study was con-
ducted in health facilities that had used RDTs in research
settings for over a year. At the time of this evaluation, the
Uganda national malaria treatment guidelines still rec-
ommended presumptive treatment in children under five
years; so treatment of RDT negative patients with anti-
malarial drugs was expected in this context and the
under-five age-group contributed a third of the anti-
malarial prescriptions for RDT negative results. It is likely
that health workers found it socially acceptable to offer
anti-malarials to RDT negative patients. It is also possible
that health workers that lack the ability to make a differ-
ential diagnosis are more likely to give anti-malarial drugs
to RDT-negative patients so that patients appreciate the
medical care provided. Therefore, further research is
needed to understand the drivers of health workers' deci-
sions to prescribe anti-malarials despite RDT negative
results.
On the other hand, only 1% of the RDT positive
patients did not receive anti-malarials. It is likely that the
health workers thought that their illness was attributable
to another diagnosis rather than the malaria disease pro-
cess. Therefore health workers should be equipped with
skills to examine and investigate patients for alternative
causes of 'malaria-like' symptoms even with negative or
positive RDT results and appropriate referral systems
should be in place to ensure appropriate management of
non-malaria fevers that present at LLHCFs. In addition to
increasing health workers' ability to make a differential
diagnosis and recognising danger signs through adequate
training, supervision and follow-up are essential to
achieving a change in perceptions and practice in this
regard [30]. Health workers need to have confidence in
the reliability of the RDTs in order to influence the per-
ceptions of colleagues and patients about the utility of
RDTs in laboratory-confirmed malaria case management
[31] This study did not evaluate alternative treatments for
RDT negative patients and there was no documentation
of the consequences of withholding anti-malarial drugs
among RDT negative patients. It is possible that the data
collected varied over the study period by the implementa-
tion nature of the study design. However the complimen-
tary intervention-control analysis designs supports the
findings for the pre-post analysis.
Conclusions
Use of RDTs resulted in a 2-fold reduction in anti-malar-
ial drug prescription at LLHCFs. The study demonstrated
that RDT use is feasible at LLHCFs, and can lead to better
targeting of malaria treatment. Nationwide deployment
of RDTs in a systematic manner should be prioritised in
order to improve fever case management. However, there
is need to further educate HWs about the utility of RDTs
in order to maximize acceptance and uptake of the diag-
nostic tools and thereby lead to the benefits of parasito-
logical diagnosis of malaria.
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